Table 1.

 Predicted life years gained (95% confidence interval) by full compliance with lifetime use of 40 mg simvastatin daily for the population of the heart protection study (not discounted)

Age at start (years)	Five year risk of major vascular event at start of treatment
	12%	18%	22%	28%	42%
40-49	1.67 (0.84 to 2.47)	2.02 (1.13 to 2.85)	2.21 (1.27 to 3.07)	2.41 (1.45 to 3.26)	2.49 (1.55 to 3.36)
50-59	1.32 (0.66 to 2.00)	1.52 (0.82 to 2.22)	1.67 (0.94 to 2.40)	1.84 (1.07 to 2.60)	1.94 (1.18 to 2.68)
60-69	0.95 (0.47 to 1.47)	1.06 (0.55 to 1.62)	1.17 (0.63 to 1.74)	1.27 (0.71 to 1.86)	1.39 (0.82 to 1.99)
≥70	0.64 (0.31 to 0.98)	0.72 (0.36 to 1.11)	0.79 (0.41 to 1.19)	0.88 (0.48 to 1.29)	0.98 (0.56 to 1.39)